SMCA2_HUMAN - dbPTM
SMCA2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID SMCA2_HUMAN
UniProt AC P51531
Protein Name Probable global transcription activator SNF2L2
Gene Name SMARCA2 {ECO:0000312|HGNC:HGNC:11098}
Organism Homo sapiens (Human).
Sequence Length 1590
Subcellular Localization Nucleus.
Protein Description Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. Binds DNA non-specifically. [PubMed: 22952240]
Protein Sequence MSTPTDPGAMPHPGPSPGPGPSPGPILGPSPGPGPSPGSVHSMMGPSPGPPSVSHPMPTMGSTDFPQEGMHQMHKPIDGIHDKGIVEDIHCGSMKGTGMRPPHPGMGPPQSPMDQHSQGYMSPHPSPLGAPEHVSSPMSGGGPTPPQMPPSQPGALIPGDPQAMSQPNRGPSPFSPVQLHQLRAQILAYKMLARGQPLPETLQLAVQGKRTLPGLQQQQQQQQQQQQQQQQQQQQQQQPQQQPPQPQTQQQQQPALVNYNRPSGPGPELSGPSTPQKLPVPAPGGRPSPAPPAAAQPPAAAVPGPSVPQPAPGQPSPVLQLQQKQSRISPIQKPQGLDPVEILQEREYRLQARIAHRIQELENLPGSLPPDLRTKATVELKALRLLNFQRQLRQEVVACMRRDTTLETALNSKAYKRSKRQTLREARMTEKLEKQQKIEQERKRRQKHQEYLNSILQHAKDFKEYHRSVAGKIQKLSKAVATWHANTEREQKKETERIEKERMRRLMAEDEEGYRKLIDQKKDRRLAYLLQQTDEYVANLTNLVWEHKQAQAAKEKKKRRRRKKKAEENAEGGESALGPDGEPIDESSQMSDLPVKVTHTETGKVLFGPEAPKASQLDAWLEMNPGYEVAPRSDSEESDSDYEEEDEEEESSRQETEEKILLDPNSEEVSEKDAKQIIETAKQDVDDEYSMQYSARGSQSYYTVAHAISERVEKQSALLINGTLKHYQLQGLEWMVSLYNNNLNGILADEMGLGKTIQTIALITYLMEHKRLNGPYLIIVPLSTLSNWTYEFDKWAPSVVKISYKGTPAMRRSLVPQLRSGKFNVLLTTYEYIIKDKHILAKIRWKYMIVDEGHRMKNHHCKLTQVLNTHYVAPRRILLTGTPLQNKLPELWALLNFLLPTIFKSCSTFEQWFNAPFAMTGERVDLNEEETILIIRRLHKVLRPFLLRRLKKEVESQLPEKVEYVIKCDMSALQKILYRHMQAKGILLTDGSEKDKKGKGGAKTLMNTIMQLRKICNHPYMFQHIEESFAEHLGYSNGVINGAELYRASGKFELLDRILPKLRATNHRVLLFCQMTSLMTIMEDYFAFRNFLYLRLDGTTKSEDRAALLKKFNEPGSQYFIFLLSTRAGGLGLNLQAADTVVIFDSDWNPHQDLQAQDRAHRIGQQNEVRVLRLCTVNSVEEKILAAAKYKLNVDQKVIQAGMFDQKSSSHERRAFLQAILEHEEENEEEDEVPDDETLNQMIARREEEFDLFMRMDMDRRREDARNPKRKPRLMEEDELPSWIIKDDAEVERLTCEEEEEKIFGRGSRQRRDVDYSDALTEKQWLRAIEDGNLEEMEEEVRLKKRKRRRNVDKDPAKEDVEKAKKRRGRPPAEKLSPNPPKLTKQMNAIIDTVINYKDRCNVEKVPSNSQLEIEGNSSGRQLSEVFIQLPSRKELPEYYELIRKPVDFKKIKERIRNHKYRSLGDLEKDVMLLCHNAQTFNLEGSQIYEDSIVLQSVFKSARQKIAKEEESEDESNEEEEEEDEEESESEAKSVKVKIKLNKKDDKGRDKGKGKKRPNRGKAKPVVSDFDSDEEQDEREQSEGSGTDDE
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
93PhosphorylationVEDIHCGSMKGTGMR
EEEEECCCCCCCCCC
23.7923401153
172PhosphorylationSQPNRGPSPFSPVQL
CCCCCCCCCCCHHHH
41.2130266825
175PhosphorylationNRGPSPFSPVQLHQL
CCCCCCCCHHHHHHH
27.7830266825
190AcetylationRAQILAYKMLARGQP
HHHHHHHHHHHCCCC
23.1026051181
194MethylationLAYKMLARGQPLPET
HHHHHHHCCCCCCHH
40.08115917169
263PhosphorylationLVNYNRPSGPGPELS
EECCCCCCCCCCCCC
55.1523312004
270PhosphorylationSGPGPELSGPSTPQK
CCCCCCCCCCCCCCC
47.1729255136
273PhosphorylationGPELSGPSTPQKLPV
CCCCCCCCCCCCCCC
57.1329255136
274PhosphorylationPELSGPSTPQKLPVP
CCCCCCCCCCCCCCC
32.6429255136
288PhosphorylationPAPGGRPSPAPPAAA
CCCCCCCCCCCCHHH
32.1228348404
316PhosphorylationQPAPGQPSPVLQLQQ
CCCCCCCCCCHHHHH
21.5427067055
322PhosphorylationPSPVLQLQQKQSRIS
CCCCHHHHHHHHCCC
35.1517081983
325PhosphorylationVLQLQQKQSRISPIQ
CHHHHHHHHCCCCCC
33.3417081983
326PhosphorylationLQLQQKQSRISPIQK
HHHHHHHHCCCCCCC
38.3223401153
329PhosphorylationQQKQSRISPIQKPQG
HHHHHCCCCCCCCCC
18.1629255136
333AcetylationSRISPIQKPQGLDPV
HCCCCCCCCCCCCHH
39.7726051181
333UbiquitinationSRISPIQKPQGLDPV
HCCCCCCCCCCCCHH
39.77-
381UbiquitinationTKATVELKALRLLNF
CCHHHHHHHHHHHHH
31.69-
408PhosphorylationRRDTTLETALNSKAY
HCCCHHHHHHCCHHH
39.29-
413AcetylationLETALNSKAYKRSKR
HHHHHCCHHHHHHHH
55.4526051181
413UbiquitinationLETALNSKAYKRSKR
HHHHHCCHHHHHHHH
55.4521890473
413 (in isoform 1)Ubiquitination-55.4521890473
413 (in isoform 2)Ubiquitination-55.4521890473
415PhosphorylationTALNSKAYKRSKRQT
HHHCCHHHHHHHHHH
15.63-
416AcetylationALNSKAYKRSKRQTL
HHCCHHHHHHHHHHH
55.8726051181
431AcetylationREARMTEKLEKQQKI
HHHHHHHHHHHHHHH
53.4326051181
437AcetylationEKLEKQQKIEQERKR
HHHHHHHHHHHHHHH
45.8023749302
447AcetylationQERKRRQKHQEYLNS
HHHHHHHHHHHHHHH
45.5026051181
447UbiquitinationQERKRRQKHQEYLNS
HHHHHHHHHHHHHHH
45.50-
460AcetylationNSILQHAKDFKEYHR
HHHHHHHHHHHHHHH
62.6725953088
463UbiquitinationLQHAKDFKEYHRSVA
HHHHHHHHHHHHHHH
68.45-
472UbiquitinationYHRSVAGKIQKLSKA
HHHHHHHHHHHHHHH
32.02-
505MethylationIEKERMRRLMAEDEE
HHHHHHHHHHHCCHH
21.33-
514PhosphorylationMAEDEEGYRKLIDQK
HHCCHHHHHHHHHHH
14.0921406692
541PhosphorylationDEYVANLTNLVWEHK
HHHHHHHHHHHHHHH
26.72-
575PhosphorylationENAEGGESALGPDGE
HHCCCCCCCCCCCCC
31.8823403867
587PhosphorylationDGEPIDESSQMSDLP
CCCCCCCCCCCCCCC
23.3223401153
588PhosphorylationGEPIDESSQMSDLPV
CCCCCCCCCCCCCCC
28.0530266825
591PhosphorylationIDESSQMSDLPVKVT
CCCCCCCCCCCCEEE
28.4923927012
604AcetylationVTHTETGKVLFGPEA
EEECCCCCEEECCCC
43.0923954790
604UbiquitinationVTHTETGKVLFGPEA
EEECCCCCEEECCCC
43.0921890473
604 (in isoform 1)Ubiquitination-43.0921890473
604 (in isoform 2)Ubiquitination-43.0921890473
611PhosphorylationKVLFGPEAPKASQLD
CEEECCCCCCHHHHH
17.6417081983
615PhosphorylationGPEAPKASQLDAWLE
CCCCCCHHHHHHHHH
37.0817081983
627PhosphorylationWLEMNPGYEVAPRSD
HHHCCCCCCCCCCCC
14.4217081983
633PhosphorylationGYEVAPRSDSEESDS
CCCCCCCCCCCCCCC
44.4222817900
638PhosphorylationPRSDSEESDSDYEEE
CCCCCCCCCCCCCCC
38.0617081983
640PhosphorylationSDSEESDSDYEEEDE
CCCCCCCCCCCCCHH
51.9117081983
642PhosphorylationSEESDSDYEEEDEEE
CCCCCCCCCCCHHHH
29.2317081983
651PhosphorylationEEDEEEESSRQETEE
CCHHHHHHHHHHHHH
33.8217081983
652PhosphorylationEDEEEESSRQETEEK
CHHHHHHHHHHHHHH
41.0617081983
666PhosphorylationKILLDPNSEEVSEKD
HHHCCCCCHHCCHHH
40.2930266825
670PhosphorylationDPNSEEVSEKDAKQI
CCCCHHCCHHHHHHH
42.0630266825
672AcetylationNSEEVSEKDAKQIIE
CCHHCCHHHHHHHHH
56.3223236377
680PhosphorylationDAKQIIETAKQDVDD
HHHHHHHHHHHCCCC
28.8428985074
689PhosphorylationKQDVDDEYSMQYSAR
HHCCCCHHHHCHHCC
19.2124043423
690PhosphorylationQDVDDEYSMQYSARG
HCCCCHHHHCHHCCC
9.4324043423
693PhosphorylationDDEYSMQYSARGSQS
CCHHHHCHHCCCCCH
8.8224043423
694PhosphorylationDEYSMQYSARGSQSY
CHHHHCHHCCCCCHH
8.4624043423
698PhosphorylationMQYSARGSQSYYTVA
HCHHCCCCCHHHHHH
15.4825849741
700PhosphorylationYSARGSQSYYTVAHA
HHCCCCCHHHHHHHH
23.0827080861
701PhosphorylationSARGSQSYYTVAHAI
HCCCCCHHHHHHHHH
8.7728985074
756PhosphorylationDEMGLGKTIQTIALI
HCCCCCHHHHHHHHH
19.2721406692
759PhosphorylationGLGKTIQTIALITYL
CCCHHHHHHHHHHHH
12.3621406692
764PhosphorylationIQTIALITYLMEHKR
HHHHHHHHHHHHHCC
16.0821406692
765PhosphorylationQTIALITYLMEHKRL
HHHHHHHHHHHHCCC
9.3221406692
803PhosphorylationAPSVVKISYKGTPAM
CCCEEEEEECCCHHH
18.3127174698
804PhosphorylationPSVVKISYKGTPAMR
CCEEEEEECCCHHHH
19.5327174698
807PhosphorylationVKISYKGTPAMRRSL
EEEEECCCHHHHHHH
12.0627174698
820PhosphorylationSLVPQLRSGKFNVLL
HHHHHHHCCCCCEEE
55.7329083192
828PhosphorylationGKFNVLLTTYEYIIK
CCCCEEEEEHHHHHC
24.1525954137
829PhosphorylationKFNVLLTTYEYIIKD
CCCEEEEEHHHHHCC
17.8324719451
830PhosphorylationFNVLLTTYEYIIKDK
CCEEEEEHHHHHCCC
11.0824719451
832PhosphorylationVLLTTYEYIIKDKHI
EEEEEHHHHHCCCHH
9.4925954137
842UbiquitinationKDKHILAKIRWKYMI
CCCHHHHEEEEEEEE
29.38-
862AcetylationRMKNHHCKLTQVLNT
HHCCCCCCCHHHHCC
50.6525953088
880PhosphorylationAPRRILLTGTPLQNK
CCCEEECCCCCHHHC
35.2520068231
882PhosphorylationRRILLTGTPLQNKLP
CEEECCCCCHHHCHH
18.6520068231
931PhosphorylationVDLNEEETILIIRRL
CCCCHHHHHHHHHHH
25.1028555341
940AcetylationLIIRRLHKVLRPFLL
HHHHHHHHHHHHHHH
47.7826051181
956PhosphorylationRLKKEVESQLPEKVE
HHHHHHHHCCCHHHH
42.0417081983
961AcetylationVESQLPEKVEYVIKC
HHHCCCHHHHHHHCC
38.1326051181
961UbiquitinationVESQLPEKVEYVIKC
HHHCCCHHHHHHHCC
38.13-
967AcetylationEKVEYVIKCDMSALQ
HHHHHHHCCCHHHHH
17.7126051181
967UbiquitinationEKVEYVIKCDMSALQ
HHHHHHHCCCHHHHH
17.71-
971PhosphorylationYVIKCDMSALQKILY
HHHCCCHHHHHHHHH
16.75-
978PhosphorylationSALQKILYRHMQAKG
HHHHHHHHHHHHHCC
11.2718083107
996AcetylationTDGSEKDKKGKGGAK
CCCCCCCCCCCCHHH
74.6068845
997AcetylationDGSEKDKKGKGGAKT
CCCCCCCCCCCHHHH
75.8119608861
999AcetylationSEKDKKGKGGAKTLM
CCCCCCCCCHHHHHH
64.1519608861
1003AcetylationKKGKGGAKTLMNTIM
CCCCCHHHHHHHHHH
45.5368857
1004PhosphorylationKGKGGAKTLMNTIMQ
CCCCHHHHHHHHHHH
30.61-
1008PhosphorylationGAKTLMNTIMQLRKI
HHHHHHHHHHHHHHH
12.12-
1020PhosphorylationRKICNHPYMFQHIEE
HHHCCCHHHHHHHHH
11.74-
1035PhosphorylationSFAEHLGYSNGVING
HHHHHHCCCCCCCCH
12.81-
1046PhosphorylationVINGAELYRASGKFE
CCCHHHHHHHCCCHH
8.81-
1051AcetylationELYRASGKFELLDRI
HHHHHCCCHHHHHHH
32.9226051181
1051UbiquitinationELYRASGKFELLDRI
HHHHHCCCHHHHHHH
32.9221890473
1051 (in isoform 1)Ubiquitination-32.9221890473
1051 (in isoform 2)Ubiquitination-32.9221890473
1057MethylationGKFELLDRILPKLRA
CCHHHHHHHHHHHHH
32.11-
1102PhosphorylationRLDGTTKSEDRAALL
EECCCCCCHHHHHHH
42.5128258704
1183AcetylationTVNSVEEKILAAAKY
ECCCHHHHHHHHHHH
29.5226051181
1183UbiquitinationTVNSVEEKILAAAKY
ECCCHHHHHHHHHHH
29.52-
1189AcetylationEKILAAAKYKLNVDQ
HHHHHHHHHCCCCCH
37.8925953088
1189UbiquitinationEKILAAAKYKLNVDQ
HHHHHHHHHCCCCCH
37.89-
1190PhosphorylationKILAAAKYKLNVDQK
HHHHHHHHCCCCCHH
18.91-
1191UbiquitinationILAAAKYKLNVDQKV
HHHHHHHCCCCCHHH
32.64-
1197SumoylationYKLNVDQKVIQAGMF
HCCCCCHHHHHHCCC
36.52-
1197SumoylationYKLNVDQKVIQAGMF
HCCCCCHHHHHHCCC
36.52-
1197UbiquitinationYKLNVDQKVIQAGMF
HCCCCCHHHHHHCCC
36.52-
1203SulfoxidationQKVIQAGMFDQKSSS
HHHHHHCCCCCCCCH
3.6221406390
1207AcetylationQAGMFDQKSSSHERR
HHCCCCCCCCHHHHH
54.9025953088
1207UbiquitinationQAGMFDQKSSSHERR
HHCCCCCCCCHHHHH
54.90-
1208PhosphorylationAGMFDQKSSSHERRA
HCCCCCCCCHHHHHH
31.2921406692
1209PhosphorylationGMFDQKSSSHERRAF
CCCCCCCCHHHHHHH
42.6321406692
1210PhosphorylationMFDQKSSSHERRAFL
CCCCCCCHHHHHHHH
36.1421406692
1271AcetylationDARNPKRKPRLMEED
HHCCCCCCCCCCCCC
40.3912429859
1282PhosphorylationMEEDELPSWIIKDDA
CCCCCCCCEEECCHH
43.4622199227
1286SumoylationELPSWIIKDDAEVER
CCCCEEECCHHHHEE
40.18-
1286UbiquitinationELPSWIIKDDAEVER
CCCCEEECCHHHHEE
40.1821906983
1286 (in isoform 1)Ubiquitination-40.1821890473
1286 (in isoform 2)Ubiquitination-40.1821890473
1295PhosphorylationDAEVERLTCEEEEEK
HHHHEEECCHHHHHH
24.8825159151
1302AcetylationTCEEEEEKIFGRGSR
CCHHHHHHHCCCCCC
46.7627452117
1302UbiquitinationTCEEEEEKIFGRGSR
CCHHHHHHHCCCCCC
46.76-
1308PhosphorylationEKIFGRGSRQRRDVD
HHHCCCCCCCCCCCC
24.7127251275
1316PhosphorylationRQRRDVDYSDALTEK
CCCCCCCHHHHCCHH
14.3227642862
1323UbiquitinationYSDALTEKQWLRAIE
HHHHCCHHHHHHHHH
41.3521890473
1323 (in isoform 1)Ubiquitination-41.3521890473
1323 (in isoform 2)Ubiquitination-41.3521890473
1337SulfoxidationEDGNLEEMEEEVRLK
HCCCHHHHHHHHHHH
6.0021406390
1373PhosphorylationKRRGRPPAEKLSPNP
HHCCCCCHHHCCCCC
29.2817081983
1377PhosphorylationRPPAEKLSPNPPKLT
CCCHHHCCCCCCHHH
33.4322167270
1384PhosphorylationSPNPPKLTKQMNAII
CCCCCHHHHHHHHHH
25.9223403867
1393 (in isoform 2)Phosphorylation-16.9327251275
1400 (in isoform 2)Phosphorylation-15.1217081983
1401 (in isoform 2)Phosphorylation-10.8317081983
1406PhosphorylationDRCNVEKVPSNSQLE
HHCCCEECCCCCCEE
3.8817525332
1406 (in isoform 2)Phosphorylation-3.8827251275
1408PhosphorylationCNVEKVPSNSQLEIE
CCCEECCCCCCEEEE
52.69-
1410PhosphorylationVEKVPSNSQLEIEGN
CEECCCCCCEEEECC
40.2426657352
1414 (in isoform 2)Phosphorylation-12.8127251275
1418PhosphorylationQLEIEGNSSGRQLSE
CEEEECCCCCCCCEE
45.0517081983
1419PhosphorylationLEIEGNSSGRQLSEV
EEEECCCCCCCCEEE
41.8317081983
1432PhosphorylationEVFIQLPSRKELPEY
EEEEECCCCCCCHHH
65.66-
1434AcetylationFIQLPSRKELPEYYE
EEECCCCCCCHHHHH
68.8626051181
1434UbiquitinationFIQLPSRKELPEYYE
EEECCCCCCCHHHHH
68.86-
1439PhosphorylationSRKELPEYYELIRKP
CCCCCHHHHHHHHCC
10.57-
1508PhosphorylationSARQKIAKEEESEDE
HHHHHHHHHHHCCCC
69.9618669648
1512PhosphorylationKIAKEEESEDESNEE
HHHHHHHCCCCCCHH
54.3420164059
1516PhosphorylationEEESEDESNEEEEEE
HHHCCCCCCHHHHHH
62.9620164059
1528PhosphorylationEEEDEEESESEAKSV
HHHHHHHCHHHHHHH
50.1030278072
1530PhosphorylationEDEEESESEAKSVKV
HHHHHCHHHHHHHEE
52.7323927012
1537AcetylationSEAKSVKVKIKLNKK
HHHHHHEEEEECCCC
7.9014657023
1538AcetylationEAKSVKVKIKLNKKD
HHHHHEEEEECCCCC
28.5314657023
1544AcetylationVKIKLNKKDDKGRDK
EEEECCCCCCCCCCC
70.8214657023
1546AcetylationIKLNKKDDKGRDKGK
EECCCCCCCCCCCCC
65.2814657023
1547AcetylationKLNKKDDKGRDKGKG
ECCCCCCCCCCCCCC
67.0188949
1551AcetylationKDDKGRDKGKGKKRP
CCCCCCCCCCCCCCC
62.2519666589
1553AcetylationDKGRDKGKGKKRPNR
CCCCCCCCCCCCCCC
73.6116916647
1555AcetylationGRDKGKGKKRPNRGK
CCCCCCCCCCCCCCC
49.4416916647
1556AcetylationRDKGKGKKRPNRGKA
CCCCCCCCCCCCCCC
80.0914657023
1562AcetylationKKRPNRGKAKPVVSD
CCCCCCCCCCCCCCC
50.4214657023
1564AcetylationRPNRGKAKPVVSDFD
CCCCCCCCCCCCCCC
41.6614657023
1564PhosphorylationRPNRGKAKPVVSDFD
CCCCCCCCCCCCCCC
41.6618669648
1568PhosphorylationGKAKPVVSDFDSDEE
CCCCCCCCCCCCHHH
32.5629255136
1572PhosphorylationPVVSDFDSDEEQDER
CCCCCCCCHHHHHHH
47.0929255136
1582PhosphorylationEQDEREQSEGSGTDD
HHHHHHHHCCCCCCC
38.8918669648
1585PhosphorylationEREQSEGSGTDDE--
HHHHHCCCCCCCC--
34.1718669648
1587PhosphorylationEQSEGSGTDDE----
HHHCCCCCCCC----
41.8125849741

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of SMCA2_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of SMCA2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of SMCA2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SSXT_HUMANSS18physical
14603256
SMRC1_HUMANSMARCC1physical
11238380
RPB1_HUMANPOLR2Aphysical
11238380
SIN3A_HUMANSIN3Aphysical
11238380
HDAC1_HUMANHDAC1physical
11238380
HDAC2_HUMANHDAC2physical
11238380
RBBP4_HUMANRBBP4physical
11238380
ESR1_HUMANESR1physical
9099865
PHB_HUMANPHBphysical
12065415
ARI1A_HUMANARID1Aphysical
8895581
SMRC2_HUMANSMARCC2physical
8895581
SMRC1_HUMANSMARCC1physical
8895581
RPB1_HUMANPOLR2Aphysical
8895581
SMCE1_HUMANSMARCE1physical
8895581
ACL6A_HUMANACTL6Aphysical
8895581
SNF5_HUMANSMARCB1physical
8895581
ARI1B_HUMANARID1Bphysical
12200431
ACL6B_MOUSEActl6bphysical
12437990
ACL6B_HUMANACTL6Bphysical
12437990
RUVB1_HUMANRUVBL1physical
11839798
ACL6A_HUMANACTL6Aphysical
11839798
ACL6A_MOUSEActl6aphysical
12437990
ACL6A_HUMANACTL6Aphysical
12437990
CEBPB_HUMANCEBPBphysical
10619021
MYB_HUMANMYBphysical
10619021
MECP2_HUMANMECP2physical
15696166
ARI1A_HUMANARID1Aphysical
16940996
SMRC2_HUMANSMARCC2physical
16940996
SMRC1_HUMANSMARCC1physical
16940996
SMRC1_HUMANSMARCC1physical
16452305
CDX2_HUMANCDX2physical
19371634
ARI1A_HUMANARID1Aphysical
14559996
SMRC2_HUMANSMARCC2physical
14559996
SMRC1_HUMANSMARCC1physical
14559996
ANM5_HUMANPRMT5physical
14559996
SMRD1_HUMANSMARCD1physical
14559996
SMRD2_HUMANSMARCD2physical
14559996
SMCE1_HUMANSMARCE1physical
14559996
ACL6A_HUMANACTL6Aphysical
14559996
SNF5_HUMANSMARCB1physical
14559996
SMCA4_HUMANSMARCA4physical
14559996
SIN3A_HUMANSIN3Aphysical
14559996
HDAC2_HUMANHDAC2physical
14559996
PRP6_HUMANPRPF6physical
16341228
KHDR1_HUMANKHDRBS1physical
16341228
RPB1_HUMANPOLR2Aphysical
16341228
TAF1_HUMANTAF1physical
12453419
CHD3_HUMANCHD3physical
12453419
SIN3A_HUMANSIN3Aphysical
12453419
SMRC2_HUMANSMARCC2physical
12453419
SMRC1_HUMANSMARCC1physical
12453419
TAF6_HUMANTAF6physical
12453419
HDAC1_HUMANHDAC1physical
12453419
HDAC2_HUMANHDAC2physical
12453419
RBBP4_HUMANRBBP4physical
12453419
RBBP7_HUMANRBBP7physical
12453419
SNF5_HUMANSMARCB1physical
12453419
TBP_HUMANTBPphysical
12453419
MBD3_HUMANMBD3physical
12453419
TAF9_HUMANTAF9physical
12453419
SAP30_HUMANSAP30physical
12453419
RAN_HUMANRANphysical
12453419
SIN3A_HUMANSIN3Aphysical
15314177
NR0B2_HUMANNR0B2physical
15314177
PHB_HUMANPHBphysical
15141164
NONO_HUMANNONOphysical
18042045
SFPQ_HUMANSFPQphysical
18042045
SMCA4_HUMANSMARCA4physical
18042045
SNF5_HUMANSMARCB1physical
18042045
REQU_HUMANDPF2physical
20460684
SMRC1_HUMANSMARCC1physical
20460684
SMRC2_HUMANSMARCC2physical
20460684
SMRD1_HUMANSMARCD1physical
20460684
ACL6A_HUMANACTL6Aphysical
20460684
SMCE1_HUMANSMARCE1physical
20460684
ZMAT3_HUMANZMAT3physical
20460684
BCL7A_HUMANBCL7Aphysical
20460684
GEMI_HUMANGMNNphysical
17261582
CEBPB_HUMANCEBPBphysical
17257825
MECP2_HUMANMECP2physical
20093853
CBX5_HUMANCBX5physical
20011120
H33_BOVINH3F3Aphysical
20011120
H31_HUMANHIST1H3Aphysical
20011120
EP300_HUMANEP300physical
21079652
CBP_HUMANCREBBPphysical
21079652
KAT2B_HUMANKAT2Bphysical
21079652
NR0B2_HUMANNR0B2physical
21566081
SMRC1_HUMANSMARCC1physical
22939629
SMRC2_HUMANSMARCC2physical
22939629
SMRD1_HUMANSMARCD1physical
22939629
SNF5_HUMANSMARCB1physical
22939629
SMCA4_HUMANSMARCA4physical
22939629
SMCE1_HUMANSMARCE1physical
22939629
SMRD3_HUMANSMARCD3physical
22939629
SMRD2_HUMANSMARCD2physical
22939629
TOP2B_HUMANTOP2Bphysical
22939629
ARI1A_HUMANARID1Aphysical
11318604
TAT_HV1H2tatphysical
16601680
BEND7_HUMANBEND7physical
25416956
ACL6A_HUMANACTL6Aphysical
26344197
BCL7A_HUMANBCL7Aphysical
26344197
BCL7B_HUMANBCL7Bphysical
26344197
BCL7C_HUMANBCL7Cphysical
26344197
REQU_HUMANDPF2physical
26344197
DPF3_HUMANDPF3physical
26344197
FUBP1_HUMANFUBP1physical
26344197
HMGB1_HUMANHMGB1physical
26344197
FUBP2_HUMANKHSRPphysical
26344197
RPAC1_HUMANPOLR1Cphysical
26344197
SIN3A_HUMANSIN3Aphysical
26344197
SNF5_HUMANSMARCB1physical
26344197
SMRC1_HUMANSMARCC1physical
26344197
SMRC2_HUMANSMARCC2physical
26344197
SMRD2_HUMANSMARCD2physical
26344197
SMRD3_HUMANSMARCD3physical
26344197
SSXT_HUMANSS18physical
26344197
BRCA1_HUMANBRCA1physical
27591253
BARD1_HUMANBARD1physical
27591253
SPTA1_HUMANSPTA1physical
16889989

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
601358Nicolaides-Baraitser syndrome (NCBRS)
181500Schizophrenia (SCZD)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of SMCA2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-604; LYS-997 AND LYS-999,AND MASS SPECTROMETRY.
"Substrate and functional diversity of lysine acetylation revealed bya proteomics survey.";
Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.-J., Zhao Y.;
Mol. Cell 23:607-618(2006).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-1551; LYS-1553 AND LYS-1555,AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-329; SER-1512 ANDSER-1516, AND MASS SPECTROMETRY.
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography.";
Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.;
Proteomics 8:1346-1361(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1568 AND SER-1572, ANDMASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-175; SER-329; SER-1512;SER-1516; SER-1528; SER-1568; SER-1572; SER-1582; SER-1585 ANDTHR-1587, AND MASS SPECTROMETRY.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1410, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-329; SER-956; SER-1377;SER-1418; SER-1419; SER-1568 AND SER-1572, AND MASS SPECTROMETRY.
"Global phosphoproteome analysis on human HepG2 hepatocytes usingreversed-phase diagonal LC.";
Gevaert K., Staes A., Van Damme J., De Groot S., Hugelier K.,Demol H., Martens L., Goethals M., Vandekerckhove J.;
Proteomics 5:3589-3599(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1568 AND SER-1572, ANDMASS SPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-591, AND MASSSPECTROMETRY.

TOP